Skip to main content
Premium Trial:

Request an Annual Quote

Danaher, Johns Hopkins Partner to Develop Methods for Detecting Mild TBI

NEW YORK – Danaher announced on Thursday that it is partnering with Johns Hopkins University to develop methods to diagnose mild traumatic brain injuries. 

Through the collaboration, Johns Hopkins researchers will use technology from Danaher subsidiary Beckman Coulter Diagnostics to evaluate new blood-based biomarkers and potentially establish correlations between a new biomarker panel and clinical outcomes, Danaher said in a statement. The collaboration builds on recent neurological biomarker research and immunoassay detection technology developed by Beckman Coulter. 

If effective, the approach could potentially be applied to other types of brain injuries or neurodegenerative disorders, the company noted. The collaboration is part of the Danaher Beacons program, which funds product-driven scientific research with academic investigators. 

"Our latest in vitro diagnostics innovations are improving the detection of specific biomarkers found in blood when brain cells are damaged," Julie Sawyer Montgomery, VP and group executive for Danaher Diagnostics, said in a statement. "We are thrilled to partner with Johns Hopkins with the goal of leveraging these solutions to develop tests for earlier and more precise diagnosis of mild TBI, which could ultimately lead to improved treatment outcomes and faster recovery for patients."